Vericel (VCEL) Enterprise Value (2010 - 2026)
Vericel (VCEL) reported Enterprise Value of -$145.3 million for Q1 2026, down 28.74% on a YoY basis from -$204.0 million in Q1 2025, and down 5.71% sequentially from -$137.5 million in Q4 2025.
Vericel (VCEL) Enterprise Value (2010 - 2026) Analysis & Trends
Vericel (VCEL) has 15 years of Enterprise Value data on file, last reported at -$145.3 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 28.74% year-over-year to -$145.3 million; the trailing twelve-month figure through Mar 2026 stood at -$145.3 million (down 28.74% YoY), and the FY2025 full-year result was -$137.5 million, down 61.67% from the prior year.
- Enterprise Value slipped to -$145.3 million in Q1 2026, from -$137.5 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$70.4 million in Q3 2024 to a low of -$145.3 million in Q1 2026.
- A 5-year average of -$106.4 million and a median of -$110.6 million in 2024 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value advanced 27.33% in 2023 and slumped 92.43% in 2025, its largest moves.
- Tracing VCEL's Enterprise Value over 5 years: stood at -$119.5 million in 2022, then gained by 27.33% to -$86.9 million in 2023, then advanced by 2.09% to -$85.0 million in 2024, then sank by 61.67% to -$137.5 million in 2025, then fell by 5.71% to -$145.3 million in 2026.
- Business Quant data shows VCEL's Enterprise Value at -$145.3 million in Q1 2026, -$137.5 million in Q4 2025, and -$135.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | -145.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -145.35 Mn |
| Dec 31, 2025 | -137.50 Mn |
| Sep 30, 2025 | -135.38 Mn |
| Jun 30, 2025 | -116.85 Mn |
| Mar 31, 2025 | -112.90 Mn |
| Dec 31, 2024 | -85.05 Mn |
| Sep 30, 2024 | -70.35 Mn |
| Jun 30, 2024 | -75.85 Mn |
| Mar 31, 2024 | -110.65 Mn |
| Dec 31, 2023 | -86.87 Mn |
| Sep 30, 2023 | -83.56 Mn |
| Jun 30, 2023 | -97.83 Mn |
| Mar 31, 2023 | -119.28 Mn |
| Dec 31, 2022 | -119.54 Mn |
| Sep 30, 2022 | -110.94 Mn |
| Jun 30, 2022 | -100.69 Mn |
| Mar 31, 2022 | -100.55 Mn |
| Dec 31, 2021 | -103.40 Mn |
| Sep 30, 2021 | -98.29 Mn |
| Jun 30, 2021 | -90.98 Mn |